Neuphoria Therapeutics NEUP Growth Metrics (2021-2026)

NASDAQ NEUP
$2.71 +0.02 (+0.74%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Neuphoria Therapeutics Quarterly Growth Metrics

Periods 17 quarters
Latest Jun 2026

Neuphoria Therapeutics reported asset growth of 0.28% for the quarter ended Jun 2026. These growth metrics cover 17 quarters of results from Jun 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Total Debt Growth (1y) 20.23%
Share-based Compensation (QoQ)Stock Comp. (QoQ) 431.82%-94.64%169.08%-75.18%-21.57%-2.40%480.92%-6.40%-15.79%-24.99%8.61%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y) 18.29%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y) 164.29%-71.98%-63.06%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y) 2,255.69%95.06%-59.82%-80.96%-97.19%-48.87%10.38%316.21%346.83%243.43%-35.79%
Revenue (QoQ) 2,163.42%-100.09%
Return on Sales [ROS] (QoQ)ROS (QoQ) 0.06M-0.01M
Return on Equity [ROE] (QoQ)ROE (QoQ) 0.00M-122.000.01M0.00M-0.01M0.00M0.00M582.00
Return on Equity [ROE] Growth (1y)ROE Growth (1y) 0.01M-580.000.00M-0.01M0.00M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) 0.00M0.01M-107.00-963.00192.000.00M-404.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) 0.01M0.01M0.00M0.00M
Return on Assets [ROA] (QoQ)ROA (QoQ) -469.000.01M0.00M0.00M0.00M0.00M376.00
Return on Assets [ROA] Growth (1y)ROA Growth (1y) 353.000.00M-0.01M0.00M
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) -1.50%-14.31%-3.57%70.73%-7.15%
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y) -71.12%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y) -87.78%-31.42%-92.08%-8.00%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) -99.55%-42.43%32.13%-29.24%-30.52%-20.81%-99.95%38.97%31.01%
Operating Margin (QoQ) 0.06M
Operating Income (QoQ)Op. Inc (QoQ) 16.73%47.42%-128.81%34.87%-3.81%423.40%-148.72%3.13%28.16%70.16%-356.07%
Operating Income Growth (1y)Op. Inc Growth (1y) 34.75%18.66%600.29%-6.52%-58.44%-9.65%-110.12%5.30%
Net Margin (QoQ) 0.04M
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) 16.78%39.00%3.00%70.14%-141.47%681.47%-178.89%-11.13%118.82%-127.09%-880.58%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) 85.29%57.33%506.75%-230.78%-1,130.95%195.92%-104.47%44.44%
Net Income (QoQ) 16.78%39.00%3.00%70.14%-141.47%681.47%-178.89%-11.13%118.82%-127.09%-880.58%
Net Income Growth (5y) 18.72%
Net Income Growth (3y) 4.34%32.56%16.99%28.67%
Net Income Growth (1y) -21.77%-125.64%68.14%85.29%57.33%506.75%-230.78%-1,130.95%195.92%-104.47%44.44%
Net Cash Flow (QoQ)NCF (QoQ) 144.04%-192.00%365.78%-213.37%25.55%463.61%-122.83%81.03%1,606.59%-140.93%135.61%
Net Cash Flow Growth (5y)NCF Growth (5y) 37.33%
Net Cash Flow Growth (3y)NCF Growth (3y) 37.32%14.19%37.08%
Net Cash Flow Growth (1y)NCF Growth (1y) -92.50%-160.27%111.76%-22.09%-306.38%915.67%-170.07%88.28%337.25%-126.71%141.66%
Income After Tax (QoQ) 16.78%39.00%3.28%70.05%-141.47%679.52%-178.88%-11.51%118.82%-127.09%-871.06%
Income After Tax Growth (1y) 85.29%57.33%505.38%-230.61%-1,130.95%195.92%-104.48%44.79%
Free Cash Flow (QoQ)FCF (QoQ) 10.94%16.48%8.63%-47.24%24.25%441.07%-143.69%24.06%-69.22%47.60%114.87%
Free Cash Flow Growth (5y)FCF Growth (5y) -17.65%
Free Cash Flow Growth (3y)FCF Growth (3y) -11.41%15.12%23.38%
Free Cash Flow Growth (1y)FCF Growth (1y) -92.50%-160.27%72.40%-0.07%14.88%447.59%-66.19%14.28%-91.49%-129.42%110.01%
FCF Margin (QoQ) 0.06M
EPS (Diluted) (QoQ) 16.78%39.00%3.00%70.14%-141.47%681.47%-178.89%-11.13%118.82%-127.09%-880.58%
EPS (Diluted) Growth (1y) 85.29%57.33%506.75%-230.78%-1,130.95%195.92%-104.47%44.44%
EPS (Basic) (QoQ) 16.78%39.00%3.00%70.14%-141.47%681.47%-178.89%-11.13%118.82%-127.09%-880.58%
EPS (Basic) Growth (1y) 85.29%57.33%506.75%-230.78%-1,130.95%195.92%-104.47%44.44%
EBT (QoQ) 16.67%39.82%1.47%65.57%-106.17%678.80%-181.84%-8.64%118.40%-129.51%-814.92%
EBT Margin (QoQ) 0.04M
EBT Growth (1y) 82.99%57.91%504.85%-236.27%-961.00%194.70%-104.83%46.02%
EBIT (QoQ) 16.73%47.42%-128.81%34.87%-3.81%423.40%-148.72%3.13%28.16%70.16%-356.07%
EBIT Margin (QoQ) 0.06M
EBIT Growth (1y) 34.75%18.66%600.29%-6.52%-58.44%-9.65%-110.12%5.30%
EBITDA Margin (QoQ) 0.06M
Cash from Operations (QoQ)Cash from Ops. (QoQ) 10.94%16.48%8.63%-47.24%24.25%441.07%-131.30%-6.00%-69.22%47.60%135.61%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y) -17.65%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y) -11.41%15.12%23.38%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) -92.50%-160.27%72.40%-0.07%14.88%447.59%-19.07%14.28%-91.49%-129.42%133.47%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) -32.66%24.83%-17.03%49.63%-35.90%-46.25%292.32%-16.63%-3.95%62.64%-12.43%2.36%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y) 35.20%-1.46%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y) 56.60%-16.18%-47.04%-14.94%-10.24%18.10%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) 580.70%7.85%4.94%-47.69%-66.92%4.36%-0.65%-57.22%102.29%12.71%68.88%410.98%14.06%40.03%
Capital Expenditures Growth (1y)Capex Growth (1y) -50.73%
Assets (QoQ) -17.11%-20.72%69.05%-6.91%-4.36%33.84%-4.89%-17.52%
Assets Growth (5y) 107.09%-6.77%
Assets Growth (3y) 235.99%-12.14%-28.25%-13.99%-13.38%0.28%
Assets Growth (1y) 5,332.35%10.22%14.48%-36.65%-31.00%-2.87%-53.24%3.40%19.32%101.44%13.34%0.42%

Neuphoria Therapeutics Growth Metrics API

Pull Neuphoria Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NEUP&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY